Company Details
ipca
13,205
388,073
3254
ipca.com
0
IPC_3109701
In-progress

Ipca Laboratories Limited Company CyberSecurity Posture
ipca.comA consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA
Company Details
ipca
13,205
388,073
3254
ipca.com
0
IPC_3109701
In-progress
Between 750 and 799

ILL Global Score (TPRM)XXXX



No incidents recorded for Ipca Laboratories Limited in 2025.
No incidents recorded for Ipca Laboratories Limited in 2025.
No incidents recorded for Ipca Laboratories Limited in 2025.
ILL cyber incidents detection timeline including parent company and subsidiaries

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA


Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t
.png)
India Business News: Indian stock market indices, BSE Sensex and Nifty50, suffered significant declines on Friday, triggered by US recession...
Last year, cyber attacks exposed the increasing vulnerability of India's biomedical institutions. This article serves as a primer for how...
Before we start speculating on how bad cyber threats are going to get next year, let's look at some of the worst cyber attacks this year.
Leaked data (Aarti Drugs: 6 GB; Ipca Laboratories: 140 GB) includes employee records, formulation and research data, and financial and audit...
IPCA Laboratories, one of the biggest pharmaceutical companies in India, has been hit by a cybercrime and extortion group that claims to have stolen 500...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Ipca Laboratories Limited is https://www.ipca.com/.
According to Rankiteo, Ipca Laboratories Limited’s AI-generated cybersecurity score is 768, reflecting their Fair security posture.
According to Rankiteo, Ipca Laboratories Limited currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Ipca Laboratories Limited is not certified under SOC 2 Type 1.
According to Rankiteo, Ipca Laboratories Limited does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Ipca Laboratories Limited is not listed as GDPR compliant.
According to Rankiteo, Ipca Laboratories Limited does not currently maintain PCI DSS compliance.
According to Rankiteo, Ipca Laboratories Limited is not compliant with HIPAA regulations.
According to Rankiteo,Ipca Laboratories Limited is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Ipca Laboratories Limited operates primarily in the Pharmaceutical Manufacturing industry.
Ipca Laboratories Limited employs approximately 13,205 people worldwide.
Ipca Laboratories Limited presently has no subsidiaries across any sectors.
Ipca Laboratories Limited’s official LinkedIn profile has approximately 388,073 followers.
Ipca Laboratories Limited is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, Ipca Laboratories Limited does not have a profile on Crunchbase.
Yes, Ipca Laboratories Limited maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/ipca.
As of December 10, 2025, Rankiteo reports that Ipca Laboratories Limited has not experienced any cybersecurity incidents.
Ipca Laboratories Limited has an estimated 5,370 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Ipca Laboratories Limited has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
WeGIA is an open source Web Manager for Institutions with a focus on Portuguese language users. Versions 3.5.4 and below contain a Stored Cross-Site Scripting (XSS) vulnerability in the /WeGIA/html/geral/configurar_senhas.php endpoint. The application does not sanitize user-controlled data before rendering it inside the employee selection dropdown. The application retrieves employee names from the database and injects them directly into HTML <option> elements without proper escaping. This issue is fixed in version 3.5.5.
ZITADEL is an open-source identity infrastructure tool. Versions 4.0.0-rc.1 through 4.7.0 are vulnerable to DOM-Based XSS through the Zitadel V2 logout endpoint. The /logout endpoint insecurely routes to a value that is supplied in the post_logout_redirect GET parameter. As a result, unauthenticated remote attacker can execute malicious JS code on Zitadel users’ browsers. To carry out an attack, multiple user sessions need to be active in the same browser, however, account takeover is mitigated when using Multi-Factor Authentication (MFA) or Passwordless authentication. This issue is fixed in version 4.7.1.
ZITADEL is an open-source identity infrastructure tool. Versions 4.7.0 and below are vulnerable to an unauthenticated, full-read SSRF vulnerability. The ZITADEL Login UI (V2) treats the x-zitadel-forward-host header as a trusted fallback for all deployments, including self-hosted instances. This allows an unauthenticated attacker to force the server to make HTTP requests to arbitrary domains, such as internal addresses, and read the responses, enabling data exfiltration and bypassing network-segmentation controls. This issue is fixed in version 4.7.1.
NiceGUI is a Python-based UI framework. Versions 3.3.1 and below are vulnerable to directory traversal through the App.add_media_files() function, which allows a remote attacker to read arbitrary files on the server filesystem. This issue is fixed in version 3.4.0.
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions are vulnerable to authentication bypass when the authentication type is set to "webserver." When providing an Authorization header with an arbitrary value, a session is associated with the target user regardless of valid credentials. This issue is fixed in versions 16.0.44 and 17.0.23.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.